209 related articles for article (PubMed ID: 27001801)
1. Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?
Frempong KK; Walker M; Cheke RA; Tetevi EJ; Gyan ET; Owusu EO; Wilson MD; Boakye DA; Taylor MJ; Biritwum NK; Osei-Atweneboana M; Basáñez MG
Clin Infect Dis; 2016 Jun; 62(11):1338-1347. PubMed ID: 27001801
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
[TBL] [Abstract][Full Text] [Related]
3. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
[TBL] [Abstract][Full Text] [Related]
4. The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
Nikièma AS; Koala L; Sondo AK; Post RJ; Paré AB; Kafando CM; Kambiré RS; Sow B; Bougouma C; Dabiré RK; Traoré S
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009117. PubMed ID: 33647010
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
Agyemang ANO; Badu K; Baffour-Awuah S; Owusu-Dabo E; Biritwum NK; Garms R; Kruppa TF
Acta Trop; 2018 Sep; 185():357-362. PubMed ID: 29932933
[TBL] [Abstract][Full Text] [Related]
6. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
7. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin.
Otabil KB; Gyasi SF; Awuah E; Obeng-Ofori D; Atta-Nyarko RJ; Andoh D; Conduah B; Agbenyikey L; Aseidu P; Ankrah CB; Nuhu AR; Schallig HDFH
BMC Infect Dis; 2019 May; 19(1):431. PubMed ID: 31101085
[TBL] [Abstract][Full Text] [Related]
9. Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
Churcher TS; Pion SD; Osei-Atweneboana MY; Prichard RK; Awadzi K; Boussinesq M; Collins RC; Whitworth JA; Basáñez MG
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16716-21. PubMed ID: 19805362
[TBL] [Abstract][Full Text] [Related]
10. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
[TBL] [Abstract][Full Text] [Related]
11. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
[TBL] [Abstract][Full Text] [Related]
12. The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana.
Alley ES; Plaisier AP; Boatin BA; Dadzie KY; Remme J; Zerbo G; Samba EM
Trans R Soc Trop Med Hyg; 1994; 88(5):581-4. PubMed ID: 7992347
[TBL] [Abstract][Full Text] [Related]
13. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
Turner HC; Walker M; Churcher TS; Basáñez MG
Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
[TBL] [Abstract][Full Text] [Related]
14. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
[TBL] [Abstract][Full Text] [Related]
15. Evidence for Suppression of Onchocerciasis Transmission in Bioko Island, Equatorial Guinea.
Moya L; Herrador Z; Ta-Tang TH; Rubio JM; Perteguer MJ; Hernandez-González A; García B; Nguema R; Nguema J; Ncogo P; Garate T; Benito A; Sima A; Aparicio P
PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004829. PubMed ID: 27448085
[TBL] [Abstract][Full Text] [Related]
16. The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
Turner HC; Osei-Atweneboana MY; Walker M; Tettevi EJ; Churcher TS; Asiedu O; Biritwum NK; Basáñez MG
PLoS Negl Trop Dis; 2013; 7(9):e2452. PubMed ID: 24069497
[TBL] [Abstract][Full Text] [Related]
17. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection.
Vieira JC; Cooper PJ; Lovato R; Mancero T; Rivera J; Proaño R; López AA; Guderian RH; Guzmán JR
BMC Med; 2007 May; 5():9. PubMed ID: 17521449
[TBL] [Abstract][Full Text] [Related]
18. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
[TBL] [Abstract][Full Text] [Related]
19. Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
Turner HC; Churcher TS; Walker M; Osei-Atweneboana MY; Prichard RK; Basáñez MG
PLoS Negl Trop Dis; 2013; 7(4):e2169. PubMed ID: 23634234
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria.
Sam-Wobo SO; Adeleke MA; Jayeola OA; Adeyi AO; Oluwole AS; Ikenga M; Lawniye F; Gazama J; Kagni A; Kosoko TO; Agbeyangi O; Bankole S; Toé L; Mafiana CF; Yameogo L
J Vector Borne Dis; 2012 Jun; 49(2):101-4. PubMed ID: 22898482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
